Bristol Myers banks on 25-plus label expansions to help weather IRA, Revlimid generics and more

With the potential for more than two dozen label expansions on the horizon, Bristol Myers Squibb bets its pipeline can help it withstand the pressure from the Inflation Reduction Act and a trio of | With the potential for more than two dozen label expansions on the horizon, Bristol Myers Squibb…#bristolmyerssquibb

Source: Reuters: Health - September 16, 2023 Category: Consumer Health News Source Type: news